HLX vs CLOV vs OII

For growth investors, Clover Health Investments, Corp.

(CLOV) is the stronger pick with 40. 3% revenue growth year-over-year, versus -4. 9% for Helix Energy Solutions Group, Inc. (HLX). Oceaneering International, Inc. (OII) offers the better valuation at 10. 8x trailing P/E (21. 0x forward), making it the more compelling value choice. Analysts rate Helix Energy Solutions Group, Inc. (HLX) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Oceaneering International, Inc.

(OII) is the cheapest at 10. 8x versus Helix Energy Solutions Group, Inc. at 47. 9x. On forward P/E, Oceaneering International, Inc. is actually cheaper at 21. 0x.

Over the past 5 years, Oceaneering International, Inc.

(OII) delivered a total return of +148. 3%, compared to -49. 1% for Clover Health Investments, Corp. (CLOV). Over 10 years, the gap is even starker: HLX returned +37. 9% versus CLOV's -66. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Helix Energy Solutions Group, Inc.

(HLX) is the lower-risk stock at 0. 78β versus Clover Health Investments, Corp. 's 1. 36β — meaning CLOV is approximately 74% more volatile than HLX relative to the S&P 500. On balance sheet safety, Helix Energy Solutions Group, Inc. (HLX) carries a lower debt/equity ratio of 40% versus 45% for Oceaneering International, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Clover Health Investments, Corp.

(CLOV) is pulling ahead at 40. 3% versus -4. 9% for Helix Energy Solutions Group, Inc. (HLX). On earnings-per-share growth, the picture is similar: Oceaneering International, Inc. grew EPS 142. 4% year-over-year, compared to -93. 6% for Clover Health Investments, Corp.. Over a 3-year CAGR, CLOV leads at 20. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Oceaneering International, Inc.

(OII) is the more profitable company, earning 12. 7% net margin versus -4. 4% for Clover Health Investments, Corp. — meaning it keeps 12. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OII leads at 10. 9% versus -4. 4% for CLOV. At the gross margin level — before operating expenses — OII leads at 20. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Oceaneering International, Inc.

(OII) trades at 21. 0x forward P/E versus 89. 7x for Clover Health Investments, Corp. — 68. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HLX: 39. 3% to $14. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Helix Energy Solutions Group, Inc.

(HLX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 78)). Both have compounded well over 10 years (HLX: +37. 9%, CLOV: -66. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (HLX (Energy) and CLOV (Healthcare) and OII (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: HLX is a small-cap quality compounder stock; CLOV is a small-cap high-growth stock; OII is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.